Healthcare Industry News: Zimmer
News Release - November 10, 2014
Zimmer Announces FDA Clearance of the Stand-alone Optio-C(R) Anterior Cervical System for use with Structural Allograft/AutograftThe Optio-C System is a next-generation, modular stand-alone cervical device that offers allograft/autograft and PEEK options and delivers the strength, stability and fusion potential of a traditional ACDF
MINNEAPOLIS, Nov. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Zimmer Spine, a division of Zimmer Holdings, Inc., (NYSE: ZMH and SIX: ZMH), today announced the recent FDA 510(k) clearance of the Optio-C Anterior Cervical Plate for use with structural allograft/autograft as a stand-alone cervical system for cervical fusion procedures.
"Zimmer is pleased to offer the industry's first no profile stand-alone cervical device with structural allograft/autograft in one modular system. In follow up to the PEEK option we launched earlier this year, we have expanded the Optio-C System to include multiple materials," said Steve Healy, President of Zimmer Spine. "Surgeons now have a choice to use structural allograft/autograft or PEEK in their stand-alone ACDF procedures."
About the Optio-C Anterior Cervical System
The modular stand-alone Optio-C System offers secure fixation with no profile. The Optio-C System is comprised of one Anterior Cervical Plate, three bone screws and either a PEEK IBFD or structural allograft/autograft. The Optio-C Device is secured by an anti-migration system that is designed to maintain no profile. The system is also designed to maximize fusion with a unique load-sharing interface and multiple implant footprints. Because it has no profile, soft tissue irritation is reduced for less invasive ACDF procedures, and it eliminates the need for additional plating when addressing adjacent level disease. With plate strength equivalent to a traditional cervical plate with no profile, stability through a three-screw fixation design, the Optio-C System takes cervical stand-alone devices to the next level.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2013 sales were approximately $4.6 billion. The Company is supported by the efforts of more than 9,000 employees worldwide. More information about Zimmer is available at www.Zimmer.com.
Zimmer Spine is a division of Zimmer Holdings, Inc. Headquartered in Minneapolis, Zimmer Spine is a global leader in spine innovation, dedicated to enhancing the quality of life for spine patients worldwide by delivering comprehensive surgical solutions, training and clinical support that advance and support surgeons.
Source: Zimmer Spine
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.